Advanced systemic mastocytosis is a rare and progressive blood disorder where abnormal mast cells accumulate uncontrollably in various organs throughout the body, potentially causing organ damage and shortening life expectancy. This complex condition affects how the immune system functions and requires specialized medical care to manage its wide range of symptoms and complications.

Understanding the Scale of the Problem

Advanced systemic mastocytosis represents one of the more challenging forms of a rare disease that affects relatively few people worldwide. While systemic mastocytosis itself occurs in approximately one in every 10,000 to 20,000 individuals globally, the advanced forms are even less common.^[3] The general incidence of systemic mastocytosis is estimated at about 1.5 cases per 100,000 people, with a prevalence of approximately 25 cases per 100,000 in the population.^[3] In the United States, systemic mastocytosis affects roughly 32,000 individuals, though this includes all forms of the disease, not just the advanced types.^[15]

The disease primarily affects adults rather than children. When systemic mastocytosis occurs in childhood, it typically appears as a milder form that affects mainly the skin and often does not progress to the systemic forms that involve internal organs.^[11] Adult-onset disease, however, has a different pattern and can progress to more serious forms over time. Despite its rarity, the impact on those affected is substantial, as many patients experience years of unexplained symptoms before receiving an accurate diagnosis.

One of the most concerning aspects of this disease is the significant delay in diagnosis. Research shows that patients with systemic mastocytosis face an average delay of 58.3 months—nearly five years—before their condition is correctly identified.^[15] Another study found a median diagnostic delay of three years, with a range spanning from one to nine years.^[18] During this extended period, patients often consult multiple healthcare providers across various specialties, including urgent care and emergency services, seeking answers for their puzzling and often debilitating symptoms.

What Causes This Disease

The root cause of advanced systemic mastocytosis lies in genetic changes that occur within cells. Research has identified that approximately 95% of cases involve a specific genetic mutation called KIT D816V.^[5] To understand how this mutation causes disease, it helps to know what happens normally in the body. The KIT gene provides instructions for making a protein that acts like a switch controlling the growth and survival of mast cells. In healthy individuals, this switch turns on and off as needed, keeping mast cell numbers in proper balance.^[20]

When the KIT D816V mutation occurs, however, this switch becomes stuck in the “on” position. The result is that mast cells receive constant signals to grow and multiply, even when the body doesn’t need more of them. This leads to an excessive accumulation of abnormal mast cells in various organs throughout the body.^[20] Research shows that about 80% of people with systemic mastocytosis carry genetic mutations in the KIT gene.^[4]

These abnormal mast cells differ from normal ones in important ways. Not only do they multiply uncontrollably, but they also tend to release their chemical contents more easily and inappropriately. The genetic mutation that drives systemic mastocytosis originates in hematopoietic stem cells, which are the master cells in bone marrow that give rise to all types of blood cells.^[3] Because the mutation occurs at this fundamental level, it can affect the entire lineage of mast cells produced by the body.

Risk Factors and Who Gets Affected

Unlike many diseases where clear risk factors have been identified, advanced systemic mastocytosis appears to occur randomly without obvious environmental or lifestyle triggers that increase susceptibility. The disease can affect adults of any age, though the adult-onset form typically appears in people over 30 years of age. The condition does not show a strong preference for one gender over another, affecting both men and women.

Because the genetic mutations responsible for the disease occur spontaneously in bone marrow cells during a person’s lifetime, traditional risk factors such as diet, exercise habits, environmental exposures, or family history do not appear to play significant roles in who develops the condition. The rarity of the disease and its sporadic occurrence make it challenging for researchers to identify specific populations at higher risk.

One factor that does influence outcomes, however, is the presence of other blood disorders. Some people with systemic mastocytosis also develop associated hematologic conditions, including myeloproliferative neoplasms (disorders where the bone marrow makes too many blood cells) or myelodysplastic syndrome (conditions where blood cells don’t develop properly).^[6] About one-fifth of people with systemic mastocytosis develop these associated blood conditions, which represents a more complex form of the disease requiring additional treatment considerations.^[4]

Recognizing the Symptoms

The symptoms of advanced systemic mastocytosis can be extensive and varied, making the condition difficult to recognize and diagnose. The wide range of symptoms occurs because abnormal mast cells can accumulate in virtually any organ system, and because these cells release numerous chemical substances that affect the body in multiple ways. Each person with the disease may experience a different combination of symptoms, and some patients may not experience all possible symptoms.

Skin manifestations are common and may include rash-like lesions, flushing where the skin suddenly becomes red and warm, itching that can be severe, and hives. Some people develop a specific type of skin marking called urticaria pigmentosa, which appears as dark, itchy bumps on the skin.^[4] When touched or rubbed, affected areas may turn red, swell, or become itchier—a phenomenon that can help healthcare providers recognize the condition.

Digestive system symptoms frequently trouble those with advanced systemic mastocytosis. Patients may experience persistent nausea, vomiting, diarrhea, abdominal pain or cramping, and acid reflux. These symptoms occur because mast cells in the digestive tract release substances like histamine that increase stomach acid production and affect intestinal function. In some cases, excessive mast cells in the stomach lining can lead to peptic ulcer disease, where open sores develop in the stomach or upper intestine.^[2]

Cardiovascular symptoms can be particularly concerning and may include low blood pressure (hypotension), dizziness, heart palpitations where the heart feels like it’s racing or fluttering, and chest pain. In severe cases, patients may experience anaphylaxis, a life-threatening allergic reaction that can cause cardiovascular collapse if not treated immediately.^[4] People with systemic mastocytosis have a higher risk of experiencing these severe allergic reactions compared to the general population.

Bone and muscle problems affect many patients with advanced forms of the disease. Bone pain can be significant, and the accumulation of abnormal mast cells in bones can lead to osteoporosis (weakening of the bones) or osteopenia (lower than normal bone density). In aggressive forms of the disease, abnormal mast cells may actually grow into bone tissue, causing osteolysis (breakdown of bone) and making bones more fragile and prone to fractures.^[2]

Neurological and cognitive symptoms can significantly impact quality of life. Patients often report brain fog, memory problems, difficulty concentrating, headaches, depression, anxiety, and mood changes.^[5] These symptoms likely result from the effects of mast cell mediators on the nervous system and brain function. The chronic nature of these cognitive difficulties can affect work performance, relationships, and daily activities.

Blood-related abnormalities are common in advanced systemic mastocytosis. Many patients develop anemia (low red blood cell count), which causes fatigue and weakness. Some experience cytopenia, meaning reduced numbers of various blood cells, which can lead to problems with blood clotting and increased susceptibility to infections.^[2] Organ enlargement, particularly of the liver (hepatomegaly) and spleen (splenomegaly), occurs when abnormal mast cells accumulate in these organs.^[2]

Additional symptoms that patients may experience include extreme tiredness that doesn’t improve with rest, shortness of breath, nasal congestion, unexplained weight loss, and swollen lymph nodes (lymphadenopathy).^[5] The symptom burden in advanced systemic mastocytosis is often substantial and can severely impact a person’s ability to carry out normal daily activities and maintain employment.

Prevention Strategies

Because advanced systemic mastocytosis results from spontaneous genetic mutations that occur during a person’s lifetime, there are no known ways to prevent the disease from developing initially. The genetic changes happen randomly in bone marrow cells, and no lifestyle modifications, dietary changes, or environmental precautions have been identified that can prevent these mutations from occurring.

However, for people already diagnosed with systemic mastocytosis, including advanced forms, there are important prevention strategies focused on avoiding situations that trigger mast cell activation and managing symptoms effectively. These preventive measures can help reduce the frequency and severity of symptom flares and potentially prevent life-threatening complications.

One of the most critical prevention strategies involves identifying and avoiding personal triggers that cause mast cells to release their chemical contents. Common triggers include alcohol, which many patients with mastocytosis cannot tolerate; spicy foods that can stimulate mast cell release; sudden changes in temperature, whether hot or cold; physical factors like skin friction or pressure; strenuous exercise that may be too vigorous; stress and emotional upset; and certain medications.^[1] Each person may have different triggers, so keeping a symptom diary to identify individual patterns can be helpful.

Insect sting prevention is particularly important because people with systemic mastocytosis have heightened risks of severe allergic reactions to stings. For those with documented allergies to insect venom, especially from bees, wasps, or other stinging insects, venom immunotherapy is not just recommended but considered mandatory.^[8] This treatment involves receiving gradually increasing doses of venom to build tolerance and reduce the risk of life-threatening reactions to future stings.

Medication management forms another essential aspect of prevention. Patients should always inform healthcare providers, including dentists, emergency room staff, and specialists, about their mastocytosis diagnosis before receiving any new medications or undergoing procedures. Certain drugs can trigger mast cell activation and should be avoided. Healthcare providers can consult specialized lists of medications that are safer for patients with mastocytosis.

All patients with systemic mastocytosis should carry self-injectable epinephrine at all times and know how to use it. These emergency injections can be lifesaving if a severe allergic reaction or anaphylaxis occurs.^[8] Family members, close friends, and coworkers should also be trained to recognize signs of anaphylaxis and know how to administer the epinephrine injection if the patient becomes unable to do so themselves.

How the Disease Affects the Body

To understand how advanced systemic mastocytosis affects the body, it’s important to first understand what mast cells normally do. Mast cells are a type of white blood cell that forms part of the immune system. They originate in the bone marrow and then travel throughout the body to take up residence in tissues, particularly in areas that interface with the outside world, such as the skin, the lining of the digestive tract, airways, and blood vessels.^[1]

In their normal role, mast cells act as sentinels or first responders when the body encounters potential threats like allergens, parasites, or other invaders. When mast cells detect these threats, they release a variety of chemical substances stored inside them. These chemicals include histamine, which most people recognize as the substance blocked by antihistamine medications; heparin, a compound that affects blood clotting; leukotrienes and prostaglandins, which promote inflammation; platelet-activating factor; and various enzymes called proteases.^[1]

When released in appropriate amounts at the right times, these substances help the body mount an effective immune response. However, in advanced systemic mastocytosis, several abnormal processes occur simultaneously that disrupt normal body functions. First, the number of mast cells becomes excessive due to uncontrolled proliferation driven by genetic mutations. Second, these abnormal mast cells are prone to releasing their chemical contents too easily, in response to triggers that wouldn’t normally cause such reactions. Third, the abnormal mast cells accumulate in organs where they shouldn’t be present in large numbers, causing direct tissue damage and organ dysfunction.

The excess release of mast cell mediators creates a state similar to a continuous allergic reaction throughout the body. Histamine overload causes blood vessels to dilate, leading to flushing, low blood pressure, and in severe cases, cardiovascular collapse. It also increases stomach acid production, contributing to ulcers and digestive symptoms. Excessive histamine in the skin causes itching, hives, and skin lesions. In the brain and nervous system, these chemical mediators can affect mood, cognition, and pain perception.

The physical accumulation of abnormal mast cells in organs causes additional problems beyond the effects of released chemicals. In the bone marrow, excessive mast cells can interfere with normal blood cell production, leading to anemia and reduced numbers of other blood cells. When mast cells infiltrate bones themselves, they can trigger bone remodeling processes that weaken bone structure, causing osteoporosis and increasing fracture risk. In some cases, particularly in aggressive forms of the disease, mast cells directly invade and destroy bone tissue.

In the liver and spleen, accumulation of abnormal mast cells causes these organs to enlarge. This enlargement can be felt during physical examination and seen on imaging tests. As the organs become infiltrated with mast cells, their normal functions may become impaired. The liver may become less efficient at processing toxins and producing essential proteins. An enlarged spleen may trap and destroy too many blood cells, worsening anemia and other blood count problems.

In the digestive tract, mast cell infiltration combined with excessive mediator release creates multiple problems. Increased stomach acid production damages the stomach lining, potentially causing ulcers. Abnormal gut motility and increased intestinal permeability can lead to chronic diarrhea and poor nutrient absorption. Some patients develop significant malabsorption, where the intestines cannot properly extract nutrients from food, contributing to weight loss and nutritional deficiencies.

The cardiovascular effects of advanced systemic mastocytosis extend beyond the acute symptoms of flushing and low blood pressure. Chronic release of mast cell mediators can affect heart rhythm, causing palpitations and potentially more serious arrhythmias. The sudden massive release of mediators during severe episodes or anaphylaxis can cause profound drops in blood pressure that may lead to shock—a life-threatening condition where inadequate blood flow reaches vital organs.

In advanced forms of systemic mastocytosis, the disease demonstrates its most severe pathophysiological effects through organ damage that compromises function. This damage can be progressive, meaning it worsens over time if the disease remains uncontrolled. The extent and pattern of organ involvement varies between individuals, but when multiple organs are affected simultaneously, the complexity of managing the disease increases substantially. Understanding these underlying mechanisms helps explain why treatment approaches must address both the excessive mast cell numbers and the symptoms caused by mast cell mediator release.